![](/img/cover-not-exists.png)
Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy
Bringeland, Gerd Haga, Blaser, Nello, Myhr, Kjell-Morten, Vedeler, Christian Alexander, Gavasso, SoniaVolume:
7
Journal:
Neurology - Neuroimmunology Neuroinflammation
DOI:
10.1212/NXI.0000000000000678
Date:
May, 2020
File:
PDF, 1.04 MB
2020